To view this email as a web page, click here.

TOP STORIES
 
Top Ways Drug Launch Pricing is Changing
Here’s what’s shaking up the drug launch pricing space.
Experts weigh in
 
New Strategies for Outcomes-Based Contracting
Executives from diagnostics, payer, pharma, and patient care companies recently got together to share stakeholder insights on outcomes-based contracting.
Read More
ADVERTISEMENT
 
Study Provides 'Proof of Concept' that Genetic Findings Can Lead to Drug Development
A new study that sheds light on genes and bone fracture risk may help identify some targets for drug development.
Read More
 
DIGITAL EDITION
Check out our October issue featuring:
 • Healthcare Disruptors
 • PBMs and Performance-based Neworks
 • Build a Pipeline of Future Leaders
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.